HARBIN, China, March 15 /PRNewswire-Asia-FirstCall/ -- Renhuang Pharmaceuticals, Inc. (Pink Sheets: RHGP) ("Renhuang" or the "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM") in China, today announced it will host a conference call at 10:00 a.m. Eastern Time on Wednesday, March 17, 2010, to discuss financial results for the first quarter of its fiscal year 2010, ended January 31, 2010.
Joining Mr. Shaoming Li, Renhuang's Chairman and CEO, will be Ms. Yan Yi Chen, Chief Financial Officer, and Mr. Guangtao Li, Vice President.
To participate in the conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: 877-812-1464. International callers should dial +1 706-902-4248. The conference ID number for the call is 62436009.
If you are unable to participate in the call at this time, a replay will be available on Wednesday, March 17, 2010 at 12:00 a.m. Eastern Time, through Tuesday, March 30, 2010. To access the replay, dial 800-642-1687. International callers should dial +1 706-645-9291. The conference ID number for the replay is 62436009.
About Renhuang Pharmaceuticals, Inc.
Renhuang Pharmaceuticals, Inc. is engaged in the research, development, manufacturing, and distribution of botanical products, bio-pharmaceutical products, and traditional Chinese medicines ("TCM"), in the People's Republic of China. All of the Company's products are produced at its three GMP-certified production facilities in Ah City, Dongfanghong and Qingyang. The Company distributes its botanical anti-depression and nerve-regulation products, biopharmaceutical products, and botanical antibiotic and OTC TCMs through its extensive distribution network of over 3,000 distributors and more than 70 sales centers across 24 provinces in China.
For more information, please contact: Company Contact: Renhuang Pharmaceuticals, Inc. Ms. Portia Tan, IR Contact Phone: +86-451-5392-5461 Email: firstname.lastname@example.org CCG Investor Relations: Ms. Lei Huang, Account Manager Phone: +1-646-833-3417 (New York) Email: email@example.com Web: http://www.ccgirasia.com Mr. Crocker Coulson, President Phone: +1-646-213-1915 (New York) Email: firstname.lastname@example.org
SOURCE Renhuang Pharmaceuticals, Inc.Back to top
|SOURCE Renhuang Pharmaceuticals, Inc.|
Copyright©2010 PR Newswire.
All rights reserved